Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Validation of Mixing Processes – V 2.0

Posted on By

SOP for Validation of Mixing Processes – V 2.0

Procedure for Validation of Mixing Processes

Department Quality Assurance (QA)/Production/Research & Development (R&D)
SOP No. SOP/Ointment/111
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the systematic approach for the validation of mixing processes used in ointment manufacturing. This ensures that mixing parameters are optimized, reproducible, and meet product quality specifications.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA), Production, and Research & Development (R&D) departments involved in the validation of mixing processes for ointment manufacturing.

3. Responsibilities

  • Production Supervisor: Oversees mixing process and ensures adherence to validation protocol.
  • QA Officer: Verifies validation process compliance and reviews test results.
  • R&D Scientist: Defines critical mixing parameters and ensures process optimization.
  • Validation Team: Conducts validation trials and compiles data.
  • QA Manager: Approves validation protocol and final validation report.
See also  Ointments: SOP for Maintaining Scraper Blade Mixers - V 2.0

4. Accountability

The QA and Production Managers are accountable for ensuring the mixing process validation is performed according to regulatory guidelines and GMP requirements.

5. Procedure

5.1 Validation Planning

  • Prepare a Mixing Process Validation Protocol outlining:
    • Objective and scope of validation
    • Batch size and equipment used
    • Mixing speed, duration, and temperature control
    • Acceptance criteria for homogeneity, viscosity, and pH
  • Define sampling points for evaluation of process parameters.
  • Ensure
that mixing equipment is calibrated and operational before validation.

5.2 Execution of Validation Batches

  • Conduct at least three consecutive mixing validation batches to confirm process consistency.
  • Ensure each batch follows the same mixing procedure, including:
    • Loading sequence of raw materials
    • Mixing time and speed
    • Temperature monitoring
    • Homogenization process
  • Collect in-process samples at predefined intervals.

5.3 Testing and Evaluation of Validation Data

  • Test each sample for critical quality attributes, including:
    • Homogeneity (assay and active ingredient distribution)
    • Viscosity (Brookfield or Rheometer test)
    • pH stability
    • Microbial contamination
    • Phase separation
  • Compile data and compare against predefined acceptance criteria.

5.4 Process Optimization

  • If deviations are observed, adjust mixing parameters accordingly.
  • Perform additional validation trials if required.
  • Document all process optimizations in the Validation Report.

5.5 Approval and Finalization

  • QA must review and approve the Mixing Validation Report.
  • Ensure that final parameters are incorporated into the Master Batch Record (MBR).
  • Maintain validation records for regulatory audits.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • MBR – Master Batch Record
  • R&D – Research & Development

7. Documents

  • Mixing Validation Protocol (Annexure-1)
  • Mixing Validation Report (Annexure-2)

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO GMP Guidelines for Process Validation

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Mixing Validation Protocol

Validation Parameter Specification Acceptance Criteria
Mixing Speed 500-1000 rpm ±10% Variation
Mixing Time 30-60 minutes No phase separation
Temperature 40°C ± 2°C Stable viscosity

Annexure-2: Mixing Validation Report

Batch Number Mixing Speed Time Homogeneity Viscosity Final Approval
OINT-1101 800 rpm 45 min Compliant Pass QA Manager
OINT-1102 750 rpm 50 min Compliant Pass QA Manager

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
See also  Ointments: SOP for Conducting Periodic Revalidation of Utilities - V 2.0
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Capsule: SOP for Using Automated Weighing Systems – V 2.0
Next Post: SOP for Record-Keeping of Raw Materials Held in Quarantine – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version